Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.41 USD | -0.54% | -9.74% | -20.38% |
Mar. 27 | Vaccinex, Inc. announced that it expects to receive $1.49961 million in funding | CI |
Mar. 04 | Vaccinex, Inc. Announces Chief Financial Officer Changes, Effective March 14, 2024 | CI |
Chart calendar VACCINEXPAR
Upcoming events on VACCINEXPAR
No events available
Past events on VACCINEXPAR
2023-11-13 08:00 am | Q3 2023 Earnings Release |
2023-11-03 | Society for Immunotherapy of Cancer Meeting |
2023-11-03 09:00 am | Society for Immunotherapy of Cancer Meeting |
2023-10-23 | Clinical Trials on Alzheimer Disease conference |
2023-09-30 | Keystone Symposium |
2023-09-29 04:40 pm | AACR Special Conference in Cancer Research: Pancreatic Cancer |
2023-09-28 08:35 am | CHI Discovery on Target conference |
2023-09-26 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
2023-09-08 08:30 am | Extraordinary Shareholders Meeting |
2023-08-14 08:10 am | Q2 2023 Earnings Release |
2023-06-09 10:00 am | Jefferies Global Healthcare Conference |
2023-06-04 | BIO International Convention |
2023-06-01 | American Society of Clinical Oncology Conference |
2023-05-15 04:45 pm | Q1 2023 Earnings Release |
2023-05-14 | PEGS Boston Summit |
2023-05-10 | Annual General Meeting |
2023-04-03 08:00 am | Q4 2022 Earnings Release |
2023-03-24 02:00 pm | AAIC Advancements Immunity Conference |
2022-11-14 08:30 am | Q3 2022 Earnings Release |
2022-11-11 05:20 pm | Society for Immunotherapy of Cancer Meeting - Abstract No - 613 |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,72 0,62 17.4% | 0,52 0,57 -7.6% | 0,63 0,62 1.63% |
EBITDA Million USD | Released Forecast Spread | -27,1 -26,0 -4.07% | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -27,3 -26,4 -3.41% | -32,0 -34,5 7.16% | -28,3 -31,4 9.69% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,5 -29,3 -0.78% | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
Net income Million USD | Released Forecast Spread | -29,5 -29,3 -0.78% | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
EPS USD | Released Forecast Spread | -1 186 -937 -26.68% | -519 -558 6.97% | -323 -341 5.23% |
Announcement Date | 13/03/19 | 09/03/20 | 31/03/21 |
Past sector events for VACCINEXPAR
- Stock
- Equities
- Stock VACCINEXPAR - Nasdaq
- Calendar VACCINEXPAR